Researcher develops potential vaccine for Newcastle disease, ILT
The research was made possible by an endowing USPOULTRY Foundation gift from Pilgrim’s
USPOULTRY and the USPOULTRY Foundation have announced the completion of a funded research project at Auburn University in Auburn, Ala., in which a researcher has developed a potential new vaccine for both Newcastle disease and infectious laryngotracheitis. The research was made possible by an endowing Foundation gift from Pilgrim’s, and the research project is part of the Association’s comprehensive research program encompassing all phases of poultry and egg production and processing. A brief summary of the completed project is shown below. A complete report, along with information on other Association research, may be obtained by going to USPOULTRY’s website, www.uspoultry.org.
The project summary is as follows.
Project #F060: Development of an Improved Recombinant Infectious Laryngotracheitis Vaccine
Dr. Joseph Giambrone at the Poultry Science Department of Auburn University recently completed a research project in which he created a new vaccine candidate for an important disease of chickens, infectious laryngotracheitis (ILT). This new vaccine was created by inserting a gene from ILT virus into the B1 Newcastle disease vaccine, which is commonly used in broilers at one day of age. The vaccine is continuing to be evaluated for its ability to safely protect against both Newcastle disease and ILT when applied at the hatchery.